Back to Results
First PageMeta Content
Allergology / Immune system / Immunology / Type 1 hypersensitivity / Ibuprofen / Over-the-counter drug / Urticaria / Allergy / Aspirin / Medicine / Non-steroidal anti-inflammatory drugs / Health


Evergreen the OTC Review R. William Soller, PhD Principal, sollerphd.com FDA Hearing on OTC Review March 25-26, 2013
Add to Reading List

Open Document

File Size: 1,17 MB

Share Result on Facebook

Company

American Cyanamid / Scientific Affairs Lederle Labs / Sterling Drug Inc. / /

Facility

University of California / /

IndustryTerm

monograph drug product / /

MedicalCondition

blisters / allergic reaction / severe allergic reaction / diseases / Erythema Multiforme / OTC Warning Allergy / Stevens Johnson Syndrome / pain reliever/fever / Study^^ Allergy / hives / shock / Ibuprofen Allergy / induced allergy / rash / wheezing / OTC Label Allergy / Toxic Epidermal Necrolysis / asthma / serious allergic reaction / /

Organization

Center for Self Care / FDA / University of California San Francisco / /

Person

Silver Spring / Stevens Johnson / Bill Soller / /

Position

Director of OTC Drug Development / Glenbrook Division VP / Director / VP Science & Technology / Officer / Professor of Clinical Pharmacy Exec. / /

Product

ibuprofen / /

Technology

Drug Development / /

SocialTag